HAEMONETICS CORP — Director's Dealing 2011

Apr 7, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2011-04-05

Reporting Person: LOPEZ ALICIA R (VP, Corporate Affairs)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-04-05	Common Stock	D	155	$66.22	Disposed	2815	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	100	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Non-Qualified Stock Option (right to buy)	$52.94	2016-10-24	Common Stock (7732)	7732	Direct

Footnotes

F1: Pursuant to a 10b5-1 Plan to cover tax liability for released shares.

F2: Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.

F3: Grant to reporting person of right to buy shares of common stock exercisable 100% on 4/1/2011. Grant was made under 2005 Long Term Incentive Compensation Plan.